Pharmaceutical Investment

The EU reports no current antibiotic shortages, signaling progress in pharmaceutical self-sufficiency. This shift reflects broader EU drug manufacturing policy reforms aimed at reducing reliance on foreign API suppliers and creating new investment opportunities in European generic drug producers.